





Objective: To investigate Antioxidant and Hepatoprotective activity of various extracts of Indigofera barberi Gamble against D-Galactosamine 
induced toxicity in rats.  
Methods: Indigofera barberi Gamble is used traditionally as folk system of medicine in India for the treatment of liver diseases, and as a liver tonic. 
Petroleum ether (PEEIB), chloroform(CEIB) and ethanolic extracts (EEIB) of Indigofera barberi Gamble (aerial part of the plants extracts, 200mg/kg, 
p. o) was tested for its hepatoprotective effect against D-galactosamine induced hepatic damage in rats at a dose of (400mg/kg, i. p) to induce 
hepatotoxicity and Silymarin (25 mg/kg, i. p.) was administered as standard drug.  
Results: The biochemical parameters of liver tissue LPO, GSH, GP
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Oxidative stress, a consequence of an imbalance of pro-oxidants and 
antioxidants in the organism, has been implicated in several disease 
states, including inflammation and liver disease. The liver, because 
of its role in metabolism, is exposed to many kinds of xenobiotics 
and therapeutic agents. Moreover, the rapidly increasing morbidity 
and mortality rates from liver diseases are largely attributable to the 
repeated chemical insult either from drug abuse or from 
environmental pollution[1]. Hence, there are many researchers of 
traditional medicines attempting to develop new drugs for 
hepatitis[2]. D-Galactosamine (D-GalN) induced hepatic injury in 
animals mimics the sequences of events in human hepatitis and is 
widely used in the screening of hepatoprotective drugs.  
The advantage of this model is that DGalN potentiates the toxic 
effects of lipopolysaccharide (LPS) and produces fulminate hepatitis 
within a few hours. D-GalN is an amino sugar selectively 
metabolized by hepatocytes, which depletes the uridine phosphate 
pool, resulting in the inhibition of mRNA and protein synthesis [3]. 
This process may lead to cellular damage and inflammation, 
resulting in histological and biochemical picture that closely 
resembles viral hepatitis.  
Upon stimulation with LPS, liver macrophages secrete various pro-
inflammatory cytokines, leading to hepatic necrosis and decreased 
levels of antioxidant enzymes and the scavenging of free radicals 
and thus these models provides a practical tool for the evaluation of 
drugs and compounds that interfere with hepatic apoptosis and 
inflammatory liver injury [4]. Indigofera barberi is a small shrub 
which belongs to the family Fabaceae and is widely distributed in 
India. In particularly, it is used for various ailments including liver 
disorders and tumors, wounds, skin disease, jaundice, anthelmintic, 
nephroprotective and diabetes [5, 6]. However there is no report of 
hepatoprotective activity of Indigofera barberi has been found in 
literature. Therefore, the present study was planned to investigate 
the effect of various extracts of aerial plants of Indigofera barberi in 
D-GalN induced hepatic injury in Wistar rats. 
MATERIALS AND METHODS 
Preparation of Indigofera barberi Gamble extract 
The aerial plants of Indigofera barberi Gamble were collected from 
the forest region of Talakona (Nelakona region) of Chitoor District, 
Andhra Pradesh, India, in the month of November - 2012. The plant 
material was identified and authenticated from the Plant Anatomy 
Research Centre, Chennai, Tamil Nadu, India. Shade dried whole 
plants were powdered to moderately coarse grade. Petroleum ether, 
chloroform and ethanolic extracts of aerial plants were obtained by 
using Soxhlet extractor. The extracts were concentrated under 
reduced pressure under controlled temperature (40-50ºC) using 
rota-vapour. Suspension of each extract was freshly prepared using 
0.1% Tween 80, for experimental use. 
Drugs and chemicals 
Silymarin was purchased from Micro labs Ltd., Bangalore, India; 
Tween 80 were purchased from S. D. Fine Chemicals Ltd., Mumbai, 
India; D-Galactosamine (D-GalN) was purchased from Merck India, 
Ltd., Mumbai, India; and other solvents/reagents was of analytical 
grade. 
Animals 
The study was undertaken at the Central Animal House, Rajah 
Muthiah Medical College and Hospital, Annamalai University, 
Annamalai Nagar, in accordance with the National Institute of Health 
“Guide for the care and use of Laboratory Animals” (NIH, 1985). The 
study was approved by the Animal Ethical Committee of Rajah 
Muthiah Medical College and Hospital [Registration No 160/1999/ 
(CPCSEA) Annamalai Nagar, Tamil Nadu, India. Albino (Wistar) 
female rats of 180-220 gm (weighing) were used for the study and 
were fed with standard pellet diet and water ad libitum. As per the 
standard practice, the rats were acclimated 15 days before the 
commencement of the experiment. Animals were housed in well 
ventilated room (temperature 23±2
, GST, SOD and CAT values were significantly (p<0.01) altered against ethanolic 
extracts treatment of Indigofera barberi Gamble and were comparable with standard drug silymarin.  
Conclusion: Animal pretreatment with petroleum ether and chloroform extracts of Indigofera barberi Gamble did not change above mentioned 
parameters significantly. The histopathological studies also substantiates the results and hence, it can be concluded from the present study that, the 
ethanolic extracts of Indigofera barberi Gamble has appreciable hepatoprotective potential in albino rats against D-galactosamine induced hepatic 
damage. 
Keywords: D-Galactosamine, Silymarin, Indigofera barberi, Biochemical parameters, Ethanolic extract. 
oC, humidity 65-70% and 12h 
light/dark cycle). 
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Acute oral toxicity 
The acute toxicity test was performed according to the Organization 
of Economic Co-operation and Development (OECD) guidelines 423 
for testing of chemicals [17]. Female rats were used for the acute 
toxicity study. PEEIB, CEIB and EEIB extracts were given up to 2000 
mg/kg individually, by oral route through intragastric tube and the 
LD50
Rats were randomly divided into six groups of six animals each. 
Group I served as normal control and received normal saline 1 ml 
orally for 21 days. Group II served as toxic control and received 
normal saline 1 ml orally for 21 days. Group III were treated with 
25mg/kg of Silymarin orally for 21days,GroupIV were treated with 
petroleum ether extract of Indigofera barberi (PEEIB) at a dose of 
200mg/kg suspended in 0.1% Tween 80 through orally, Group V 
were treated with chloroform extract of Indigofera barberi (CEIB) at 
a dose of 200mg/kg suspended in 0.1% Tween 80 through orally, 
Group VI were treated with ethanolic extract of Indigofera barberi 
(EEIB) at a dose of 200mg/kg suspended in 0.1% Tween 80 through 
orally, Group II to group VI received D-GalN(400 mg/kg,i. p.) on 21st 
day. After 24 h of D-GalN administration animals in all the groups 
were humanely sacrificed using xylazine + Ketamine (16 + 100 
mg/kg, i. m), prior to biochemical analysis, each hepatic tissue 
(100mg/ml buffer) was homogenized in 50 mM phosphate buffer 
(pH 7.0).  The homogenate was then centrifuged at 10,000 rpm for 
15 min and the supernatant obtained was used for biochemical 
analysis viz.,lipid peroxides (LPO)[7], Reduced glutathione (GSH)[8], 
Glutathione peroxides (GP




)[9], Glutathione-S transferase 
(GST)[10], Superoxide dismutase (SOD)[11] and Catalase (CAT)[12] 
by using Secomam semi auto analyzer and a part of tissue was 
subjected to histopathological studies[13]. 
The statistical analysis was carried out by one way analysis of 
variance (ANOVA) followed by NewmannKeul’s multiple range tests. 
The values are represented as Mean±SEM. Probability value of P 
<0.01 was determined to be statistically significant. 
RESULTS 
The LD50
Silymarin pretreatment produced the significant increase in 
(P<0.01) Liver homogenate enzyme such as SOD, CAT, GSH, GST and 
GPxlevels and decrease the levels of LPO significantly (P<0.01) in 
group III. 
 
Table 1: Results of the antioxidantactivity of various extracts of Indigofera barberi Gamble 
 value for PEEIB, CEIB and EEIB were found to be 
2000mg/kg/oral body weight individually. There was no alteration 
in gross behavior effects visually when compared with control group 
animals. In liver homogenate, there was significant decrease in SOD, 
CAT,GSH,GST and GPx levels and increase in LPO levels was 
observed in animals treated with D-GalN400mg/kg (group II) as 
compared to the normal control group (Group I). Pretreatment with 
ethanolic extract of Indigofera barberi(EEIB) at a dose of 200mg/kg 
orally for 21 days increase the levels of above parameters like SOD, 
CAT,GSH,GST and GPx levels and decrease levels of LPO significantly 
(P<0.01) in group VI. Whereas animal’s pretreatment with 
petroleum ether and chloroform extracts of Indigofera barberidid 




























































































Values expressed: Levels of lipid peroxides (LPO) – nmolmalondialdehyde released/mg protein; Reduced glutathione (GSH) – μmol (oxidized min-1 
mg-1 protein);Glutathione peroxidise (GPx) – nmol (oxidized min-1 mg-1 protein);Glutathione-S transferase (GST)- μmol (1-chloro-2, 4-
dinitrobenzene conjugate formed min-1 mg-1 protein);Catalase (CAT) – nmol (H2O2
 
 Histopathological observations  
Histology of liver sections of normal control animals (Group I) 
showed normal liver architecture with were brought out the central 
vein, were preserved cytoplasm and prominent nucleus and 
nucleolus (Fig. 1). The liver sections of D-GalN treated animals 
(Group II) showed hepatic cells toxicity characterized by 
inflammatory cell collection, scattered inflammation across liver 
parenchyma, focal necrosis and swelling up of vascular endothelial 
cells (Fig. 2). Silymarin (Group-III) exhibited protection from D-GalN 
induced changes in the liver (Fig. 3). Pretreatment with ethanolic 
extract of Indigofera barberi (EEIB) at a dose of 200mg (group VI) 
appeared to significantly prevent the D-GalN toxicity as revealed by the 
hepatic cells with were preserved cytoplasm and pretreatment also 
caused marked decrease in inflammatory cells (Fig. 6). 
DISCUSSION 
 decomposed min-1 mg-1);Superoxide dismutase (SOD) - (one 
unit of the SOD activity is the amount of protein required to give 50% inhibition of epinephrine autoxidation). Values are expressed as Mean ± SEM. 
* – values are significantly different from Normal control at P< 0.01.** – values are significantly different from Toxic control (G2) at p< 0.01. 
The LD50 value for PEEIB, CEIB and EEIB was found to be 
2000mg/kg/oral body weight individually. In the present study 
treatment of rats with D-GalN elicited a significant increase in the 
LPO. EEIB treatment prevented the increase in LPO indicating the 
protective effect of EEIB against lipid per oxidation. Moreover, it has 
been observed that chronic EEIB significantly decreased lipid per 
oxidation and increased endogenous antioxidants such as SOD, 
CAT,GSH,GST and GPx, Since administration of EEIB prevented the 
hepatic GPx depletion, it appears that the protective effect of EEIB 
involves the maintenance of antioxidant capacity in protecting the 
hepatic tissue against oxidative stress. Excessive production in 
hydroxyl radicals in the blood and liver has previously been 
demonstrated in rats, indicating that circulating pro-inflammatory 
cytokines, such as TNF-α, which triggers hepatic injury, were 
increased, at least in part, by a free-radical mediated apoptosis 
mechanism [14]. In this study, treatment with EEIB probably 
ameliorated oxidative liver injury through its antioxidant effect 
which further alleviated hepatic injury as shown as biochemical 
findings. In addition, several reports showed that hepatic 
antioxidant defense system associated with antioxidant enzymes 
such as SOD, CAT, GSH, GST and GPx, are disrupted in D-GalN treated 
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rat. Accordingly as D-GalN induced-hepatotoxicity has striking 
resemblance to the human viral hepatitis [15], the present study 
confirms the hepatoprotective efficacy of EEIB against D-GalN 








Fig. 1: Liver section of normal control rats showing (a): Normal liver lobular architecture with well brought out central vein and 
prominent nucleus and nucleolus; (b):D-GalN (400mg/kg. i. p) treated rats showing severe toxicity with congested blood vessels with 
inflammatory cell collection and endothelial cell swelling; (c): Treated with Silymarin 25mg/kg (p. o)+D-GalN (400mg/kg) showing only a 
few inflammatory cells around portal tract; (d): Treated with pet ether extract of Indigofera barberi (200mg/kg) + D-GalN (400mg/kg) 
showing only slight inflammation; (e): Treated with chloroform extract of Indigofera barberi (200 mg/kg) + D-GalN (400 mg/kg) showing 
only slight inflammation; (f): Treated with ethanolic extract of Indigofera barberi (200mg/kg) + D-GalN(400 mg/kg)showing slight 
inflammation. 
 
D-Galactosamine is reported to produce intensive inflammatory 
infiltration in the liver parenchyma and peripheral areas[16]. In our 
study also D-GalN administration showed severe hepatotoxicity with 
heavy infiltration of inflammatory cells around portal tract and in 
the liver parenchymal cells. Pre-treatment with EEIB and Silymarin 
for 21 days protected the rat livers from D-GalN induced 
histopathological change. 
CONCLUSION 
These observations make more evident that Indigofera barberi 
gamblei s one of the promising herbal drugs for improving defense 
mechanisms in the physiological systems against oxidative stress 
caused by the D- Galactosamine. The probable action could be due to 
stabilizing the hepatocellular membrane, inhibiting neutrophil 
infiltration into the liver cells, preventing the process of lipid 
peroxidation, preventing inactivation of antioxidant enzymes. It 
might be used in the treatment of viral hepatitis. 
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